Enhanced Pharmacological Properties of Efavirenz Formulated as Solid Drug Nanoparticles.... "Studies to determine whether bioequivalence can be obtained with a lower dose of SDN are now planned in healthy volunteers"

Conference Reports for NATAP

20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013


Enhanced Pharmacological Properties of Efavirenz Formulated as Solid Drug Nanoparticles.... "Studies to determine whether bioequivalence can be obtained with a lower dose of SDN are now planned in healthy volunteers"

	Reported by Jules Levin CROI 2013 Philip Martin1, NJ Liptrott1, T McDonald2, M Giardiello2, P Roberts1, P Curley1, D Smith1, M Siccardi1, S Rannard2, and A Owen1 1Department of Molecular and Clinical Pharmacology, University of Liverpool, UK; 2Department of Chemistry, University of Liverpool, UK.